Biotechnology Competitors
| BST Stock | 0.23 0.01 4.55% |
Biotechnology Assets vs Aedas Homes Correlation
Pay attention - limited upside
The correlation between Biotechnology Assets SA and AEDAS is -0.74 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Assets SA and AEDAS in the same portfolio, assuming nothing else is changed.
Moving against Biotechnology Stock
Biotechnology Assets Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Biotechnology Assets and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Biotechnology and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Biotechnology Assets does not affect the price movement of the other competitor.
| 0.19 | 0.81 | 0.6 | 0.79 | -0.81 | EBRO | ||
| 0.19 | 0.28 | -0.34 | -0.18 | -0.26 | PAR | ||
| 0.81 | 0.28 | 0.6 | 0.69 | -0.81 | ETC | ||
| 0.6 | -0.34 | 0.6 | 0.7 | -0.61 | VYT | ||
| 0.79 | -0.18 | 0.69 | 0.7 | -0.74 | AEDAS | ||
| -0.81 | -0.26 | -0.81 | -0.61 | -0.74 | BST | ||
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biotechnology Stock performing well and Biotechnology Assets Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biotechnology Assets' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EBRO | 0.46 | 0.04 | 0.00 | 0.25 | 0.54 | 0.90 | 3.10 | |||
| PAR | 1.40 | (0.05) | 0.00 | 0.14 | 0.00 | 2.27 | 21.32 | |||
| ETC | 1.80 | 0.21 | 0.04 | (0.28) | 2.18 | 5.42 | 15.97 | |||
| VYT | 2.65 | 0.55 | 0.19 | 0.61 | 2.48 | 7.35 | 16.73 | |||
| AEDAS | 0.39 | 0.17 | 0.46 | 0.51 | 0.00 | 0.42 | 11.45 | |||
| BST | 2.54 | (0.56) | 0.00 | 1.38 | 0.00 | 5.26 | 15.34 |
Biotechnology Assets Competitive Analysis
The better you understand Biotechnology Assets competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Biotechnology Assets' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Biotechnology Assets' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Biotechnology Assets Competition Performance Charts
Five steps to successful analysis of Biotechnology Assets Competition
Biotechnology Assets' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Biotechnology Assets in relation to its competition. Biotechnology Assets' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Biotechnology Assets in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Biotechnology Assets' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Biotechnology Assets, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Biotechnology Assets position
In addition to having Biotechnology Assets in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Biotechnology Stock
Biotechnology Assets financial ratios help investors to determine whether Biotechnology Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Assets security.